About
Envista's site notes Mark Nance joined in 2019 ahead of the IPO and serves as SVP, General Counsel, with nearly 20 years of experience as a general counsel. He was previously Chief Legal Officer of INSYS Therapeutics, General Counsel of Mylan N.V., and led the legal teams at GE Healthcare Medical Diagnostics and Life Sciences; his public service includes the U.S. Federal Trade Commission, the U.S. Marine Corps, and the National Science Advisory Board for Biosecurity. He holds a BA from the University of Missouri and a JD from Cornell Law School.
Roles
Envista Holdings Corp.
Senior Vice President, General Counsel and Secretary · Current role
2019–present
INSYS Therapeutics, Inc.
Chief Legal Officer
—
Mylan N.V.
Senior Vice President and Global General Counsel
—
GE Healthcare
General Counsel, Medical Diagnostics and Life Sciences
—
Mylan N.V.
General Counsel
—
GE Healthcare
Legal leadership, Medical Diagnostics and Life Sciences
—
Fixed Compensation
FY 2025Salary
$559,615
ComponentAnnual base salary
All other compensation
$33,986
Total compensation
$2,645,186
Performance Compensation
Data from FY 2025Cash incentive
Non-equity incentive plan compensation
$551,425
FormCash
Target Opportunity
—
PlanExecutive Incentive Compensation Plan (ICP)
Evaluation periodFY2025
Stock awards
Stock awards
$1,125,143
FormRSUs and PSUs under the 2019 Omnibus Incentive Plan
ValuationGrant date fair value (ASC 718)
Option awards
$375,017
FormStock options under the 2019 Omnibus Incentive Plan
ValuationGrant date fair value (ASC 718)
Also at Envista Holdings Corp.
See how Top Bucket AI works for your firm
Request DemoTop Bucket AI Research
Stay ahead of private markets
Research and market intelligence for private-markets professionals.
✓
You're subscribed.
Thanks for signing up.